New

Middle East and Africa Virology Market

2021

Middle East and Africa Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)

Publication Month: Nov 2021 | Report Code: TIPRE00025741 | No. of Pages: 187 | Category: Biotechnology | Status: Published

Market Insights

Middle East and Africa Virology Market to Grow at a CAGR of 2.8% to reach US$ 221.46 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The virology market in MEA is expected to grow from US$ 182.40 million in 2021 to US$ 221.46 million by 2028; it is estimated to grow at a CAGR of 2.8% from 2021 to 2028.

The UAE, Saudi Arabia, and South Africa are economies in MEA. Plant-derived vaccines and biopharmaceuticals do not need costly fermentation and purification systems and other costs associated with cold storage, transportation, and sterile distribution when administered orally. In general, chloroplasts deliver high levels of vaccine antigen expression against bacterial, viral, and protozoan pathogens and biopharmaceuticals and the containment of transgenes by maternal inheritance. In the past eight years, the chloroplast system for therapeutic protein expression has been established. Also, the recent development of an efficient lettuce chloroplast system for oral delivery is a significant advancement. Moreover, at-home health diagnostics is gaining popularity among patients. As a response to the virology market, players are developing at-home test kits that help in easy and quick diagnosis and help in taking immediate medical treatment. For instance, in November 2020, the USFDA issued an emergency use authorization (EUA) Lucira COVID-19 all-in-one test kit.

Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries like Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in a deep economic recession due to the US sanctions. Additionally, tightened financial condition is also decreasing the economic activities in the region. COVID-19 is the second coronavirus outbreak that has affected the Middle East, following the MERS-CoV reported in Saudi Arabia in 2012. Many countries are facing a shortage of testing kits in the region. Considering this, many government organizations are coming forward to help countries with a lack of resources. For instance, in September, The United Nations Children’s Fund (UNICEF) delivered around 115,800 Covid-19 test kits to help mitigate the Covid-19 pandemic in Nigeria. Also, the countries in the region are collaborating with international players to increase the testing capacity. In addition, the substantial direct health, and economic impacts of the Ebola epidemic in Guinea, Liberia, and Sierra Leone, diverted basic health care and government services to the outbreak, resulting in serious under-provision of health and social care. Economic growth also slowed significantly due to reduced financial investments and productivity levels during and after the outbreak. As per the Global Fund Organization, across 24 countries in Africa, only 11% of health facilities could conduct COVID-19 antigen rapid diagnostic tests, and only 8% could conduct PCR tests. Before the COVID-19, Lassa Fever was the priority, with the annual incidence of around 300,000-500,000 cases of Lassa Fever, with 5,000 related deaths in West Africa. However, COVID-19 has diverted all the rescores in handling the pandemic has impeded the growth of the other virus infections.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The MEA virology market is expected to grow at a good CAGR during the forecast period.
 MEA virology market

Get more information on this report :


MEA Virology Market Segmentation

MEA Virology Market – By Type

  • Diagnostic Test
    • DNA Virus Testing
    • RNA Virus Testing
    • Others
  • Viral Infection Controlling Techniques
    • Active Prophylaxis
    • Passive Prophylaxis
  • Antiviral Therapeutics
    • Virucidal Agents
    • Antiviral Agents
    • Immunomodulators
  • Interferons

MEA Virology Market – By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Others

MEA Virology Market – By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes

MEA Virology Market- By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

MEA Virology Market-Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline Plc
  • Illumina, Inc.
  • Johnson and Johnson Services, Inc.
  • QIAGEN
  • Siemens AG
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Virology Market – By Type

1.3.2 MEA Virology Market – By Application

1.3.3 MEA Virology Market – By End User

1.3.4 MEA Virology Market– By Country

2. MEA Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Virology Market– Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Viral Infectious Diseases

5.1.2 Increasing Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Price of Production of Products

5.3 Market Opportunities

5.3.1 Major Growth Potential in Emerging Economies

5.4 Future Trends

5.4.1 Continuous Requirement for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– MEA Analysis

6.1 MEA Virology Market Revenue Forecast and Analysis

7. MEA Virology Market Analysis – By Type

7.1 Overview

7.2 MEA Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Virology Market Analysis – By Application

8.1 Overview

8.2 MEA Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Virology Market Analysis – By End User

9.1 Overview

9.2 MEA Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Virology Market – Country Analysis

10.1.1 Overview

10.1.2 Middle East & Africa: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1 Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Saudi Arabia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2 Saudi Arabia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3 Saudi Arabia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3 Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2 UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 UAE: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 UAE Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 UAE: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2 UAE: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3 UAE: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3 UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 South Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2 South Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3 South Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3 South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1 Rest of Middle East and Africa: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.4.2.2 Rest of Middle East and Africa: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.4.2.3 Rest of Middle East and Africa: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.4.3 Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Impact of COVID-19 Pandemic on MEA Virology Market

11.1 Overview

12. MEA Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. Saudi Arabia Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5. Saudi Arabia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6. Saudi Arabia: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. Saudi Arabia: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Virology Market, By Type – Revenue and Forecast to 2028(USD Million)

Table 9. UAE Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10. UAE Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11. UAE Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12. UAE: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13. UAE: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. South Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 15. South Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16. South Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17. South Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18. South Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. South Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of Middle East and Africa Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Middle East and Africa Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Middle East and Africa Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Middle East and Africa Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Middle East and Africa: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25. Rest of Middle East and Africa: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26. Organic Developments Done by Companies

Table 27. Inorganic Developments Done by Companies

Table 28. Glossary of Terms, Virology Market

LIST OF FIGURES

Figure 1. MEA Virology Market Segmentation

Figure 2. MEA Virology Segmentation, By Country

Figure 3. MEA Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in MEA Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in MEA Virology Market

Figure 6. South Africa to Show Significant Growth During Forecast Period

Figure 7. MEA PEST Analysis

Figure 8. MEA Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. MEA Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. MEA Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. MEA Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. MEA DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. MEA RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. MEA Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. MEA Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. MEA Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. MEA Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. MEA Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. MEA Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. MEA Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. MEA Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. MEA Virology Market, by Application 2021 & 2028 (%)

Figure 24. MEA Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. MEA Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. MEA GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. MEA Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. MEA Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. MEA Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. MEA Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Middle East and Africa: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36. Middle East & Africa: Virology Treatment Market, by Country, 2021 & 2028 (%)

Figure 37. Saudi Arabia: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. UAE: Virology Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. South Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Rest of Middle East and Africa: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Impact of COVID-19 Pandemic on Virology Market in MEA Countries

  1. Abbott
  2. AbbVie Inc.
  3. F. Hoffmann-La Roche Ltd.
  4. Gilead Sciences, Inc.
  5. GlaxoSmithKline Plc
  6. Illumina, Inc.
  7. Johnson and Johnson Services, Inc.
  8. QIAGEN
  9. Siemens AG
  10. Thermo Fisher Scientific Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA Virology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the MEA Virology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025741
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.